A detailed history of Sabal Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Sabal Trust CO holds 2,549 shares of BDX stock, worth $582,421. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,549
Holding current value
$582,421
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $564,527 - $617,903
2,549 New
2,549 $614,000
Q3 2023

Oct 10, 2023

BUY
$254.9 - $283.59 $13,509 - $15,030
53 Added 5.24%
1,065 $275,000
Q2 2023

Jul 20, 2023

BUY
$238.39 - $265.32 $2,860 - $3,183
12 Added 1.2%
1,012 $267,000
Q1 2023

Apr 26, 2023

SELL
$229.71 - $259.35 $39,739 - $44,867
-173 Reduced 14.75%
1,000 $247,000
Q4 2022

Jan 31, 2023

BUY
$218.29 - $256.91 $654 - $770
3 Added 0.26%
1,173 $298,000
Q3 2022

Oct 18, 2022

BUY
$51.03 - $264.23 $1,020 - $5,284
20 Added 1.74%
1,170 $261,000
Q1 2022

Apr 14, 2022

SELL
$243.64 - $270.48 $36,546 - $40,572
-150 Reduced 11.54%
1,150 $306,000
Q4 2020

Jan 20, 2021

SELL
$221.92 - $245.94 $665,760 - $737,820
-3,000 Reduced 69.77%
1,300 $325,000
Q4 2019

Jan 14, 2020

SELL
$236.45 - $266.82 $4,019 - $4,535
-17 Reduced 0.39%
4,300 $1.17 Million
Q3 2019

Oct 15, 2019

BUY
$230.58 - $256.08 $3,919 - $4,353
17 Added 0.4%
4,317 $1.09 Million
Q1 2019

Apr 12, 2019

SELL
$206.05 - $248.17 $4,121 - $4,963
-20 Reduced 0.46%
4,300 $1.07 Million
Q2 2018

Jul 16, 2018

SELL
$208.1 - $233.85 $5,202 - $5,846
-25 Reduced 0.58%
4,320 $1.04 Million
Q1 2018

Apr 16, 2018

SELL
$205.46 - $240.27 $616 - $720
-3 Reduced 0.07%
4,345 $941,000
Q4 2017

Feb 07, 2018

BUY
$189.0 - $222.64 $5,292 - $6,233
28 Added 0.65%
4,348 $931,000
Q3 2017

Oct 17, 2017

BUY
$186.89 - $198.9 $807,364 - $859,248
4,320
4,320 $847,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.